Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Immune Response to Pneumococcal Vaccination in Aging Renal Transplant Recipients

Authors not listed

VA Office of Research and Development · 2018

Abstract

The goal of the research proposed in the current application is to first define how much antibody aging renal transplant and dialysis recipients make after they are vaccinated with the pneumonia vaccine and how this compares to similar aged persons with good renal function and healthy young adults. The investigators will study differences in the kind of B cells and markers on the B cells that are known to be important in the response to the pneumonia vaccine in aging renal transplant and aging dialysis recipients compared to similarly aged and young healthy controls. Finally, the investigators will study how safe the pneumonia vaccine is in aging renal transplants. The answers to these questions will help in designing a better vaccine for older people with a renal transplant or on dialysis.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-14 MST

Cite this

APA
Anonymous. (2018). Immune Response to Pneumococcal Vaccination in Aging Renal Transplant Recipients. <em>VA Office of Research and Development</em>. https://clinicaltrials.gov/study/NCT03802994
Vancouver
Anonymous. Immune Response to Pneumococcal Vaccination in Aging Renal Transplant Recipients. VA Office of Research and Development. 2018.
BibTeX
@misc{anon2018Immune, title = {Immune Response to Pneumococcal Vaccination in Aging Renal Transplant Recipients}, author = {Anonymous}, journal = {VA Office of Research and Development}, year = {2018}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings